Optimizing Referral Pathways for Patients With Hematuria and Moderate-Severe Proteinuria
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Clinical Trials Related to Glomerulonephritis
Related studies linked through entity extraction aliases.
Impact of Dapagliflozin for the Regulation of Immunological Activity in Membranous Nephropathy
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
The Effect of Daratumumab in Patients with Monoclonal Gammopathy of Renal Significance (MGRS) in Finland
- Status
- RECRUITING
- Phase
- PHASE2
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
- Status
- RECRUITING
- Phase
- PHASE3
Effect of Finerenone in Patients With Non-diabetic Glomerulonephritis
- Status
- RECRUITING
- Phase
- PHASE2
Biomarkers and Outcome Predictors of Pediatric Nephrotic Syndrome: A Genetic, Transcriptomic, and Secretome Multiomics Study
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
ANTI-SARS-CoV-2 SEROCONVERSIO IN IMMUNE-MEDIATED KIDNEY DISEASES
- Status
- COMPLETED
- Phase
- N/A
A Study of Rituximab in Frontline Therapy for Glomerulonephritis
- Status
- RECRUITING
- Phase
- N/A
Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of KP104 to Treat Glomerulonephritis
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Study of HRS-5965 in Healthy Subjects and Subjects With Renal Insufficiency
- Status
- COMPLETED
- Phase
- PHASE1
TESTING -ON Post-Trial ObservatioNal Cohort Study
- Status
- RECRUITING
- Phase
- N/A
Bortezomib for Treating Glomerular Diseases
- Status
- UNKNOWN
- Phase
- NA
Empagliflozin in Patients With Glomerulonephritis
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Mezagitamab in Adults With Primary Immunoglobulin A Nephropathy Receiving Stable Background Therapy
- Status
- COMPLETED
- Phase
- PHASE1
An Open-Label, Long-term Study of GFB-887 in Patients With Glomerular Kidney Diseases
- Status
- TERMINATED
- Phase
- PHASE2
Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Efficacy, Safety and PK/PD of MOR202 in Anti-PLA2R+ Membranous Nephropathy (aMN) (NewPLACE)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the Safety and Activity of Sparsentan for the Treatment of Incident Patients With Immunoglobulin A Nephropathy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy.
- Status
- RECRUITING
- Phase
- PHASE4
US Time-Harmonic Elastography for the Early Detection of Childhood Glomerulonephritis
- Status
- UNKNOWN
- Phase
- N/A